SCHEMBL2013207

SCHEMBL2013207

CCNCC(C)(O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.53
KCNN4 O15554 1/20 0.45
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
ALOX15 P16050 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28098161 0.81 RAB9A (0.36) CYP2C19KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL5142176 0.79 CYP2C19 (0.56) CYP2C19KCNN4MEN1KMT2AHIF1A
SCHEMBL19413917 0.79 TAAR1 (0.50) KCNN4MEN1KMT2ATAAR1
SCHEMBL27532067 0.79 CASR (0.40) CYP2C19HDAC3HDAC1HDAC2CYP3A4
SCHEMBL3190736 0.78 CYP2C19 (0.48) CYP2C19KMT2AHIF1AALDH1A1LMNA
SCHEMBL27511141 0.78 AOC3 (0.53) MEN1KMT2AALDH1A1HTTLMNA
Hydrochloric Acid SCHEMBL9413960 0.78 CYP2C19 (0.54) CYP2C19KCNN4MEN1KMT2AHIF1A
SCHEMBL27270010 0.77 KCNN4 (0.50) KCNN4MEN1KMT2AALDH1A1HTT
SCHEMBL14463747 0.76 CYP2C19 (0.47) CYP2C19KCNN4MEN1KMT2AHIF1A
SCHEMBL464008 0.76 CYP2C19 (0.47) CYP2C19KCNN4MEN1KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513069-B1 ANTIFUNGAL COMPOUNDS UNIV LEUVEN KATH (BE) 2014-10-15 EP disclosed
EP-2513069-A1 ANTIFUNGAL COMPOUNDS Katholieke Universiteit Leuven (BE) 2012-10-24 EP disclosed
US-20120252801-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-10-04 US disclosed
WO-2011072345-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2011-06-23 WO disclosed
CN-1326457-A 4-aminopyrrolopyrimidines as kinase inhibitors BASF AG (DE) 2001-12-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252801-A1 ANTIFUNGAL COMPOUNDS ERG28, DPM1, CYP51A1 CYP2C19 1008/4885KCNN4 4565/4885MEN1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.